Asian American Medical : Half Year Accounts

Asian American Medical Group Limited and its controlled entities
Appendix 4D Half Year Report for the period ended 28 February 2022
Table of Contents	Page
Results for Announcement to the Market	2
Corporate Directory	4
Directors' Report
5
Auditor's Independence Declaration	9
Consolidated Statement of Profit or Loss and Other Comprehensive Income	10
Consolidated Statement of Financial Position	12
Consolidated Statement of Changes in Equity	13
Consolidated Statement of Cash Flows	14
Notes to the Interim Financial Report	15
Directors' Declaration
28
Independent Auditor's Review Report
29

Appendix 4D

Asian American Medical Group Limited

Current reporting period: Previous corresponding period:

ABN 42 091 559 125

Half Year Report

All amounts are stated in Singapore Dollars.

Results for announcement to the market

6 months ended 28 February 2022 6 months ended 28 February 2021

S$'000
to	530
to	(622)
to	-
to	(622)
Please refer to the review of operations within the Directors' report on page 6.
Dividends per share
Amount
per share
of foreign
sourced	Amount
dividend	A$'000
-	-
-	-

Revenue

Loss after income tax from continuing operations Loss on sale of discontinued operation

Net loss for the period attributable to members

Commentary on results

Current period NIL

Previous corresponding period NIL

Down Down - DownAmount per share

-

--10.9%

• - 66.2% -

• - 66.2%Franked amount per

share at 30% tax

-

-

Net tangible assets and net asset value per share

28-Feb-22	31-Aug-21
Net tangible assets per ordinary share - (S cents)	1.54	1.55
1.58	1.57
Net asset value per ordinary share - (S cents)	1.54	1.55
1.58	1.57

- (A cents)*

- (A cents)*

*exchange rate used was 0.9796 S$ to 1.00 A$ (2021: 1.0287 S$ to 1.00 A$) Right-of-use asset is included for the purpose of net tangible assets calculation

Details of entities over which control has been gained or lost

Nil.

Compliance statement

This report is based on the interim financial report that has been reviewed. The review report which was not subject to qualification is included in the interim financial report.

Asian American Medical Group Limited

Corporate Directory

Directors

Mr Ang Kong Meng (Non-Executive Chairman) - appointed on 9th December 2021 Mr Evgenii Tugolukov (Non-Executive Director)

Ms Jeslyn Jacques Wee Kian Leong (Independent Non-Executive Director) Mr Pang Fey Yu (Independent Non-Executive Director)

Mr Peter Hurley (Independent Non-Executive Director) - resigned on 16 November 2021

Dato' Dr Kai Chah Tan (Executive Chairman) - deceased on 5th December 2021

Company Secretary

Dario Nazzari

Registered Office 25 Peel Street Adelaide SA 5000

Tel: [phone]

Fax: [phone] Website:www.aamg.co

Auditors

BDO Audit (SA) Pty Ltd

BDO Centre, Level 7, 420 King William Street Adelaide SA 5000

Tel: [phone] Fax: [phone]

Bankers

DBS Bank Ltd

12 Marina Boulevard

DBS Asia Central, Marina Bay Financial Centre Tower 3 Singapore 018982

Westpac Banking Corporation 114 William Street Melbourne VIC 3000

Share registry

Computershare Investor Services Pty Ltd Level 5, 115 Grenfell Street

Adelaide SA 5000

Tel: [phone] Fax: [phone]

Stock Exchange Listing

The Company's shares are quoted on the Official List of Australian Securities Exchange Limited.

ASX Code : AJJ